FDA panel backs Glaxo's cervical vaccine for women (AP)

AP - Drugmaker Merck likely will face U.S. competition for its vaccine Gardasil, after federal experts recommended rival GlaxoSmithKline's Cervarix also be approved to prevent the virus that causes most cervical cancers.

Read more | Previous | Next